BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9117915)

  • 1. The effect of thyroid hormone therapy on angiographic coronary artery disease progression.
    Perk M; O'Neill BJ
    Can J Cardiol; 1997 Mar; 13(3):273-6. PubMed ID: 9117915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical treatment of ischemic heart disease combined with hypothyroidism].
    Sawa S; Kawasuji M; Tsujiguchi H; Takemura H; Tedoriya T; Iwa T
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jul; 38(7):1106-11. PubMed ID: 2212771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of the hypothyroid patient with chest pain.
    Myerowitz PD; Kamienski RW; Swanson DK; Chopra PS; Berkoff HA; Kroncke GM; Rowe GG; Vander Ark CR; Dhanani SP
    J Thorac Cardiovasc Surg; 1983 Jul; 86(1):57-60. PubMed ID: 6602915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal daily levothyroxine dose in primary hypothyroidism. Its relation to pretreatment thyroid hormone indexes.
    Kabadi UM
    Arch Intern Med; 1989 Oct; 149(10):2209-12. PubMed ID: 2508585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
    Shimon I; Cohen O; Lubetsky A; Olchovsky D
    Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric emptying function changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy.
    Kao PF; Lin JD; Chiu CT; Hsu HT; See LC; Tzen KY
    J Gastroenterol Hepatol; 2004 Jun; 19(6):655-60. PubMed ID: 15151620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxedema coma and cardiac ischemia in relation to thyroid hormone replacement therapy in a 38-year-old Japanese woman.
    Taguchi T; Iwasaki Y; Asaba K; Takao T; Hashimoto K
    Clin Ther; 2007 Dec; 29(12):2710-4. PubMed ID: 18201588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of L-thyroxine replacement dose in elderly patients with primary hypothyroidism.
    Kabadi UM
    J Fam Pract; 1987 May; 24(5):473-7. PubMed ID: 3106558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between coronary disease and subclinical hypothyroidism: an angiographic study.
    Fiarresga AJ; Feliciano J; Fernandes R; Martins A; Pelicano N; Timóteo AT; Ferreira RC
    Rev Port Cardiol; 2009 May; 28(5):535-43. PubMed ID: 19650571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess coronary artery bypass graft mortality among women with hypothyroidism.
    Zindrou D; Taylor KM; Bagger JP
    Ann Thorac Surg; 2002 Dec; 74(6):2121-5. PubMed ID: 12643405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular effects of hypothyroidism].
    Tielens E; Visser TJ; Hennemann G; Berghout A
    Ned Tijdschr Geneeskd; 2000 Apr; 144(15):703-6. PubMed ID: 10778718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.
    Parle JV; Franklyn JA; Cross KW; Jones SR; Sheppard MC
    Br J Gen Pract; 1993 Mar; 43(368):107-9. PubMed ID: 8323787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism.
    Davis FB; LaMantia RS; Spaulding SW; Wehmann RE; Davis PJ
    Arch Intern Med; 1984 Sep; 144(9):1752-4. PubMed ID: 6433829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
    Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
    Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive thyroid hormone replacement therapy.
    Nuovo J; Ellsworth A; Christensen DB; Reynolds R
    J Am Board Fam Pract; 1995; 8(6):435-9. PubMed ID: 8585400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hypothyroidism].
    Massol J
    Rev Prat; 1998 Nov; 48(18):2027-33. PubMed ID: 9881014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice.
    De Whalley P
    Br J Gen Pract; 1995 Feb; 45(391):93-5. PubMed ID: 7702890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay monitoring of thyroid hormone concentrations in dogs on thyroid replacement therapy: 2,674 cases (1985-1987).
    Nachreiner RF; Refsal KR
    J Am Vet Med Assoc; 1992 Aug; 201(4):623-9. PubMed ID: 1517142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.